Hepatitis A Vaccine

CDC Advisory Committee Recommendations for Havrix

Published in Blood Weekly, July 10th, 1995

SmithKline Beecham, Philadelphia, Pennsylvania, the manufacturer of Havrix (Hepatitis A Vaccine, Inactivated), announced that the U.S. Centers for Disease Control and Prevention (CDC) has put forth its recommendations for use of Havrix.

An advisory committee to the CDC recommended that persons at risk for hepatitis A virus infection be immunized through vaccination. Hepatitis A virus (HAV) is highly contagious and poses a serious health risk to persons who become infected. HAV causes acute liver disease and debilitating symptoms that can last up to one year.

The CDC's Advisory Committee on Immunization Practices (ACIP) recommended that the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry